Teleflex Incorporated (NYSE:TFX) Shares Sold by Kimelman & Baird LLC

Kimelman & Baird LLC decreased its stake in Teleflex Incorporated (NYSE:TFX) by 34.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 65,260 shares of the medical technology company’s stock after selling 34,267 shares during the period. Kimelman & Baird LLC’s holdings in Teleflex were worth $11,615,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Vontobel Holding Ltd. raised its position in Teleflex by 21.9% during the fourth quarter. Vontobel Holding Ltd. now owns 1,393 shares of the medical technology company’s stock worth $248,000 after acquiring an additional 250 shares during the last quarter. JPMorgan Chase & Co. raised its position in Teleflex by 14.3% during the third quarter. JPMorgan Chase & Co. now owns 155,158 shares of the medical technology company’s stock worth $38,374,000 after acquiring an additional 19,466 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. raised its position in Teleflex by 5.2% during the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 108,231 shares of the medical technology company’s stock worth $19,263,000 after acquiring an additional 5,322 shares during the last quarter. Lecap Asset Management Ltd. acquired a new position in Teleflex during the fourth quarter worth about $729,000. Finally, Mirae Asset Global Investments Co. Ltd. raised its position in Teleflex by 35.1% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 5,875 shares of the medical technology company’s stock worth $1,053,000 after acquiring an additional 1,527 shares during the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.

Wall Street Analysts Forecast Growth

TFX has been the subject of a number of research reports. Raymond James cut shares of Teleflex from an “outperform” rating to a “market perform” rating in a research report on Friday, February 28th. Bank of America downgraded shares of Teleflex from a “neutral” rating to an “underperform” rating and lowered their price target for the stock from $235.00 to $140.00 in a report on Tuesday, March 4th. Wells Fargo & Company lowered their price target on shares of Teleflex from $214.00 to $146.00 and set an “equal weight” rating for the company in a report on Friday, February 28th. Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a report on Wednesday, March 12th. Finally, Royal Bank of Canada downgraded shares of Teleflex from an “outperform” rating to a “sector perform” rating and lowered their price target for the stock from $220.00 to $155.00 in a report on Friday, February 28th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, Teleflex presently has a consensus rating of “Hold” and a consensus target price of $182.63.

Teleflex Price Performance

Teleflex stock opened at $137.79 on Monday. Teleflex Incorporated has a 1 year low of $128.55 and a 1 year high of $249.90. The firm has a 50 day moving average price of $166.99 and a 200 day moving average price of $197.37. The company has a market cap of $6.39 billion, a price-to-earnings ratio of 27.39, a PEG ratio of 1.73 and a beta of 1.21. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42.

Teleflex (NYSE:TFX) last announced its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, beating analysts’ consensus estimates of $3.86 by $0.03. The firm had revenue of $795.40 million for the quarter, compared to analysts’ expectations of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. Sell-side analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 17th. Shareholders of record on Friday, March 7th will be given a dividend of $0.34 per share. The ex-dividend date of this dividend is Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a yield of 0.99%. Teleflex’s dividend payout ratio (DPR) is 95.77%.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.